ELIS Elis SA

Elis: Combined shareholders’ meeting of May 25, 2023

Elis: Combined shareholders’ meeting of May 25, 2023

Combined shareholders’ meeting of May 25, 2023

Saint Cloud, May 26, 2023 - The combined shareholders’ Meeting of Elis, chaired by Thierry Morin, Chairman of the Supervisory Board, in the presence of the members of the Management Board, was held on Thursday, May 25, 2023, at Maison des Travaux Publics, 3 rue de Berri, 75008 Paris, France.

The quorum was 81.63% and the shareholders approved all the resolutions put to the vote.

The General Meeting approved the annual and consolidated financial statements for fiscal year 2022 and the distribution of a sum of €0.41 per share. The amount will be detached on May 30, 2023 and paid on June 22, 2023 with an option to pay the dividend in shares to be exercised during the period from June 1 to June 16, 2023.

The shareholders approved:

  • the reappointment of Thierry Morin, Magali Chessé and Philippe Delleur as Supervisory Board member, for a term of four years, i.e., expiring at the end of the Shareholders’ Meeting that will be held in 2027 with respect to the approval of the 2026 annual accounts;
  • the appointment of Bpifrance Investissement as Supervisory Board member, for a term of three years, i.e., expiring at the end of the Shareholders’ Meeting that will be held in 2026 with respect to the approval of the 2025 annual accounts. This appointment ends his term as censor;
  • the ratification of cooptation of Michel Plantevin as member of the Supervisory Board, for the remaining term of office of his predecessor, Joy Verlé, i.e. until the general meeting that will be held in 2025 with respect to the approval of the 2024 annual accounts.



The Supervisory Board of Elis counts 11 members, of which 7 are independent, 5 are women and 2 employee representatives. The composition of the Board offers complementary experiences and reflects the diversity policy pursued by the Group.

The shareholders also approved the compensation policy of the Company’s executive officers for 2023 (i.e. the President and members of the Management Board and the President and members of the Supervisory Board), the information referred to in Article L.22-10-9 of the French commercial Code in respect of the ex-post vote on the compensation of all corporate officers and approved the fixed, variable and exceptional elements of total compensation and benefits of any kind paid or awarded for the financial year of 2022 to the members of the Management Board and the President of the Supervisory Board, in accordance with Article L.22-10-34 of the French commercial Code.

The shareholders approved the renewal of the authorization granted to the Management Board with regard to share buy backs.

The shareholders also approved the renewal of authorization and delegation to be granted to the Management Board concerning the issue of shares and other securities reserved for foreign employees, the awarding of bonus shares to employees and corporate officers as well as the delegation of authority to reduce the share capital by cancellation of shares acquired under the share buyback program.

The results of voting on all resolutions submitted to Shareholders are available on the Company’s website: at under “Shareholders Meetings.”

Contact

Nicolas Buron

Director of Investor Relations, Financing & Treasury

Phone: 30 -

Attachment



EN
26/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Elis SA

 PRESS RELEASE

Elis: Press release

Elis: Press release Saint-Cloud, 6 September 2024 – Elis confirms it has made a preliminary approach to Vestis regarding a potential acquisition. Elis regularly considers a range of strategic opportunities. There can be no assurance that these discussions will result in the signing of a transaction or other agreement. Any transaction, should one be agreed, would be in line with Elis’ commitments to its shareholders, namely: Financial discipline in terms of the amount paid for the acquisition;Retain investment grade rating and leverage of c. 2.2x adjusted EBITDA in Year 1 and c. 2.0x in...

Carole Braudeau
  • Carole Braudeau

Credit Morning 09/06/2024

Elis said to be interested by Vestis in US (Reuters) Mahle: downgraded sentiment after Q2 2024 results call Isabel Marant - conference call: New disappointment for Spring 2025 order book>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 06/09/2024

Isabel Marant - conference call : Nouvelle déception sur le carnet de commandes du printemps 2025 Elis serait intéressé par Vestis aux Etats-Unis (Reuters) Mahle : un sentiment dégradé après le call des résultats T2 2024>...

 PRESS RELEASE

Elis: Disclosure of the number of shares forming the capital and of th...

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 08 2024 DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 AOUT 2024 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social235 567 817Nombre de droits de vote théoriques267 565 661Nombre de droits de vote exerçables267 512 953 Cette déclaration est en ligne sur le site internet d’Elis DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER O...

 PRESS RELEASE

Elis announces a 2024 “Elis for All” employee share ownership plan

Elis announces a 2024 “Elis for All” employee share ownership plan Elis announces a 2024 “Elis for All” employee share ownership plan Saint-Cloud, 3 September 2024 – Elis announces the launch of a new “Elis for All” 2024 employee share ownership plan. I. ISSUER ELIS Euronext Paris regulated market (France) ISIN code for ordinary shares: FR0012435121 Share admitted to the Differed Settlement System (SRD) II. FRAMEWORK OF THE ISSUANCE – PURPOSE OF THE OFFERING Pursuant to the delegations granted in accordance with the 27th and 28th resolutions of the Extraordinary General Assembly date...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch